Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):519–526. doi: 10.1097/QAI.0000000000001844

Table 2. Odds ratios of RAL+DRV/r vs TDF/FTC+DRV/r for having moderate or severe problems in the EQ5D domains over follow up.

Odds Ratio of RAL + DRV/r vs TDF/FTC + DRV/r (95% CI)
EQ-5D Domain W4 W12 W24 W48 W96 Global
p-value
Mobility
(n=677)		 0.77
(0.32-1.90)		 0.52
(0.20-1.36)		 4.18
(1.12-15.66)		 2.19
(0.83-5.82)		 2.41
(0.97-5.96)		 0.05
Self-care
(n=677)		 1.26
(0.15-10.93)		 0.49
(0.13-1.92)		 0.71
(0.05-9.51)		 0.26
(0.03-2.63)		 0.24
(0.02-2.35)		 0.80
Usual activity
(n=676)		 0.99
(0.47-2.07)		 0.98
(0.45-2.11)		 0.98
(0.43-2.24)		 0.77
(0.35-1.66)		 0.75
(0.33-1.68)		 0.99
Pain or discomfort
(n=676)		 0.74
(0.48-1.16)		 1.13
(0.72-1.79)		 1.63
(1.01-2.64)		 0.96
(0.60-1.52)		 1.12
(0.69-1.82)		 0.26
Anxiety or depression
(n=676)		 1.09
(0.72-1.67)		 1.14
(0.74-1.74)		 0.87
(0.57-1.34)		 1.10
(0.71-1.69)		 1.33
(0.84-2.10)		 0.85